Gallagher Carol Giltner 4
4 · Atara Biotherapeutics, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Gallagher Carol Giltner
Director
Transactions
- Award
Common Stock
2023-05-31+57,000→ 189,418 total - Award
Non-Qualified Stock Option (Right to Buy)
2023-05-31+79,500→ 79,500 totalExercise: $1.53Exp: 2033-05-30→ Common Stock (79,500 underlying)
Footnotes (2)
- [F1]These restricted stock units shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
- [F2]The option shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.